全文获取类型
收费全文 | 12615篇 |
免费 | 1182篇 |
国内免费 | 1948篇 |
出版年
2024年 | 43篇 |
2023年 | 148篇 |
2022年 | 428篇 |
2021年 | 670篇 |
2020年 | 512篇 |
2019年 | 630篇 |
2018年 | 576篇 |
2017年 | 446篇 |
2016年 | 579篇 |
2015年 | 784篇 |
2014年 | 1024篇 |
2013年 | 1084篇 |
2012年 | 1276篇 |
2011年 | 1075篇 |
2010年 | 758篇 |
2009年 | 699篇 |
2008年 | 754篇 |
2007年 | 722篇 |
2006年 | 589篇 |
2005年 | 519篇 |
2004年 | 476篇 |
2003年 | 421篇 |
2002年 | 345篇 |
2001年 | 227篇 |
2000年 | 161篇 |
1999年 | 171篇 |
1998年 | 130篇 |
1997年 | 74篇 |
1996年 | 82篇 |
1995年 | 60篇 |
1994年 | 63篇 |
1993年 | 44篇 |
1992年 | 34篇 |
1991年 | 33篇 |
1990年 | 17篇 |
1989年 | 16篇 |
1988年 | 12篇 |
1987年 | 17篇 |
1986年 | 10篇 |
1985年 | 5篇 |
1984年 | 6篇 |
1983年 | 4篇 |
1982年 | 6篇 |
1981年 | 3篇 |
1973年 | 1篇 |
1972年 | 2篇 |
1971年 | 1篇 |
1970年 | 1篇 |
1967年 | 1篇 |
1950年 | 4篇 |
排序方式: 共有10000条查询结果,搜索用时 78 毫秒
91.
Yan Jia Huanhuan Jin Liyuan Gao Xiang Yang Feixia Wang Hai Ding Anping Chen Shanzhong Tan Feng Zhang Jiangjuan Shao Shijun Wang Shizhong Zheng 《Journal of cellular and molecular medicine》2020,24(9):5304-5316
A growing number of studies recognize that long non‐coding RNAs (lncRNAs) are essential to mediate multiple tumorigenic processes, including hepatic tumorigenesis. However, the pathological mechanism of lncRNA‐regulated liver cancer cell growth remains poorly understood. In this study, we identified a novel function lncRNA, named polo‐like kinase 4 associated lncRNA (lncRNA PLK4, GenBank Accession No. RP11‐50D9.3), whose expression was dramatically down‐regulated in hepatocellular carcinoma (HCC) tissues and cells. Interestingly, talazoparib, a novel and highly potent poly‐ADP‐ribose polymerase 1/2 (PARP1/2) inhibitor, could increase lncRNA PLK4 expression in HepG2 cells. Importantly, we showed that talazoparib‐induced lncRNA PLK4 could function as a tumour suppressor gene by Yes‐associated protein (YAP) inactivation and induction of cellular senescence to inhibit liver cancer cell viability and growth. In summary, our findings reveal the molecular mechanism of talazoparib‐induced anti‐tumor effect, and suggest a potential clinical use of talazoparib‐targeted lncRNA PLK4/YAP‐dependent cellular senescence for the treatment of HCC. 相似文献
92.
Jie Ouyang Zhihao Shu Shuhua Chen Hong Xiang Hongwei Lu 《Journal of cellular and molecular medicine》2020,24(18):10290-10301
There are many different types of cardiovascular diseases, which impose a huge economic burden due to their extremely high mortality rates, so it is necessary to explore the underlying mechanisms to achieve better supportive and curative care outcomes. Sphingosine 1‐phosphate (S1P) is a bioactive lipid mediator with paracrine and autocrine activities that acts through its cell surface S1P receptors (S1PRs) and intracellular signals. In the circulatory system, S1P is indispensable for both normal and disease conditions; however, there are very different views on its diverse roles, and its specific relevance to cardiovascular pathogenesis remains elusive. Here, we review the synthesis, release and functions of S1P, specifically detail the roles of S1P and S1PRs in some common cardiovascular diseases, and then address several controversial points, finally, we focus on the development of S1P‐based therapeutic approaches in cardiovascular diseases, such as the selective S1PR1 modulator amiselimod (MT‐1303) and the non‐selective S1PR1 and S1PR3 agonist fingolimod, which may provide valuable insights into potential therapeutic strategies for cardiovascular diseases. 相似文献
93.
Dafei Chai Dong Qiu Zichun Zhang Shang Yuchen Shi Gang Wang Lin Fang Huizhong Li Hailong Li Hui Tian Junnian Zheng 《Journal of cellular and molecular medicine》2020,24(18):10744-10755
Conditionally replicative adenoviruses (CRAds) were promising approach for solid tumour treatment, but its oncolytic efficiency and toxicity are still not satisfactory for further clinical application. Here, we developed the CAIX promotor (CAIXpromotor)‐controlled CRAd armed with a tumour suppressor absent in melanoma 2 (AIM2) to enhance its oncolytic potency. The CAIXpromotor‐AIM2 adenoviruses (Ad‐CAIXpromotor‐AIM2) could efficiently express E1A and AIM2 in renal cancer cells. Compared with Ad‐CAIXpromotor, Ad‐CAIXpromotor‐AIM2 significantly inhibited cell proliferation and enhanced cell apoptosis and cell killing, thus resulting in the oncolytic efficiency in 786‐O cells or OSRC‐2 cells. To explore the therapeutic effect, various Ads were intratumourally injected into OSRC‐2‐xenograft mice. The tumour growth was remarkably inhibited in Ad‐CAIXpromotor‐AIM2‐treated group as demonstrated by reduced tumour volume and weight with a low toxicity. The inflammasome inhibitor YVAD‐CMK resulted in the reduction of anti‐tumour activity by Ad‐CAIXpromotor‐AIM2 in vitro or in vivo, suggesting that inflammasome activation response was required for the enhanced therapeutic efficiency. Furthermore, lung metastasis of renal cancer mice was also suppressed by Ad‐CAIXpromotor‐AIM2 treatment accompanied by the decreased tumour fossil in lung tissues. These results indicated that the tumour‐specific Ad‐CAIXpromotor‐AIM2 could be applied for human renal cancer therapy. The therapeutic strategy of AIM2‐based CRAds could be a potential and promising approach for the therapy of primary solid or metastasis tumours. 相似文献
94.
Yuanzhi Zhu Joshua Sokolowski Xiancheng Song Yanghua He Yi Mei Gang Wu 《Liver Transplantation》2020,10(11)
Carbon‐based heteroatom‐coordinated single‐atom catalysts (SACs) are promising candidates for energy‐related electrocatalysts because of their low‐cost, tunable catalytic activity/selectivity, and relatively homogeneous morphologies. Unique interactions between single metal sites and their surrounding coordination environments play a significant role in modulating the electronic structure of the metal centers, leading to unusual scaling relationships, new reaction mechanisms, and improved catalytic performance. This review summarizes recent advancements in engineering of the local coordination environment of SACs for improved electrocatalytic performance for several crucial energy‐convention electrochemical reactions: oxygen reduction reaction, hydrogen evolution reaction, oxygen evolution reaction, CO2 reduction reaction, and nitrogen reduction reaction. Various engineering strategies including heteroatom‐doping, changing the location of SACs on their support, introducing external ligands, and constructing dual metal sites are comprehensively discussed. The controllable synthetic methods and the activity enhancement mechanism of state‐of‐the‐art SACs are also highlighted. Recent achievements in the electronic modification of SACs will provide an understanding of the structure–activity relationship for the rational design of advanced electrocatalysts. 相似文献
95.
Bing‐Qing Xiong Xinwei Zhou Gui‐Liang Xu Yuzi Liu Likun Zhu Youcheng Hu Shou‐Yu Shen Yu‐Hao Hong Si‐Cheng Wan Xiao‐Chen Liu Xiang Liu Shengli Chen Ling Huang Shi‐Gang Sun Khalil Amine Fu‐Sheng Ke 《Liver Transplantation》2020,10(4)
Alloy materials such as Si and Ge are attractive as high‐capacity anodes for rechargeable batteries, but such anodes undergo severe capacity degradation during discharge–charge processes. Compared to the over‐emphasized efforts on the electrode structure design to mitigate the volume changes, understanding and engineering of the solid‐electrolyte interphase (SEI) are significantly lacking. This work demonstrates that modifying the surface of alloy‐based anode materials by building an ultraconformal layer of Sb can significantly enhance their structural and interfacial stability during cycling. Combined experimental and theoretical studies consistently reveal that the ultraconformal Sb layer is dynamically converted to Li3Sb during cycling, which can selectively adsorb and catalytically decompose electrolyte additives to form a robust, thin, and dense LiF‐dominated SEI, and simultaneously restrain the decomposition of electrolyte solvents. Hence, the Sb‐coated porous Ge electrode delivers much higher initial Coulombic efficiency of 85% and higher reversible capacity of 1046 mAh g?1 after 200 cycles at 500 mA g?1, compared to only 72% and 170 mAh g?1 for bare porous Ge. The present finding has indicated that tailoring surface structures of electrode materials is an appealing approach to construct a robust SEI and achieve long‐term cycling stability for alloy‐based anode materials. 相似文献
96.
97.
目的:探讨莫西沙星联合用药方案对耐多药肺结核(MDR-TB)患者血清游离氨基酸和免疫功能的影响。方法:选取2015年9月到2018年1月期间我院收治的90例MDR-TB患者,根据乱数表法将患者分为研究组(n=45)、对照组(n=45),其中对照组给予左氧氟沙星联合常规化疗治疗,研究组则给予莫西沙星联合常规化疗治疗,比较两组临床疗效、痰菌转阴率、病灶吸收率、空洞闭合率、血清游离氨基酸和免疫功能,记录两组治疗期间不良反应情况。结果:研究组治疗18个月后的临床总有效率为71.11%(32/45),高于对照组的46.67%(21/45)(P0.05)。研究组治疗18个月后痰菌转阴率、病灶吸收率、空洞闭合率均较对照组高(P0.05)。两组患者治疗18个月后CD4+、免疫球蛋白A(Ig A)、免疫球蛋白G(Ig G)均升高,CD8+降低(P0.05),研究组治疗18个月后CD4+、Ig A、Ig G高于对照组,而CD8+低于对照组(P0.05)。两组治疗18个月后缬氨酸、谷氨酸均升高,且研究组高于对照组(P0.05)。两组患者总不良反应发生率比较无明显差异(P0.05)。结论:莫西沙星联合常规化疗治疗MDR-TB的疗效确切,可有效改善患者血清游离氨基酸水平,提高机体免疫功能,同时不增加不良反应发生率。 相似文献
98.
99.
为探究PPARγ与c/EBPα基因在苏太猪不同组织中的表达与脂肪沉积的关系,本实验以10月龄苏太猪为研究对象,运用实时荧光定量PCR (q RT-PCR)技术检测PPARγ与c/EBPα基因mRNA在苏太猪心、肝、脾、肺、肾、胃、背最长肌和皮下脂肪8个组织中的表达水平。结果表明,PPARγ与c/EBPα基因在苏太猪的8个组织中均有不同程度的表达,其中,PPARγ基因在苏太猪脾脏组织中的表达量最高,皮下脂肪中的表达水平仅次于脾;以背最长肌中PPARγ基因的相对表达量作对比,背最长肌与脾、肺和皮下脂肪的相对表达差异极显著(p<0.01),其余为差异不显著(p>0.05),表达量高低顺序为脾>皮下脂肪>肺>心>胃>肾>肝>背最长肌;c/EBPα基因在苏太猪的皮下脂肪的表达量最高,以背最长肌中c/EBPα基因的相对表达量作对比,在肝、脾、皮下脂肪组织中表达差异极显著(p<0.01),肺的相对表达差异显著(p<0.05),其余组织中差异不显著(p>0.05),表达量的高低顺序为皮下脂肪>肝>脾>肺>肾>心>胃>背最长肌。两基因在各组织中表达趋势趋于一致。试验结果表明PPARγ和c/EBPα基因可能对猪脂肪沉积有重要影响。 相似文献
100.
In China, three institutes for botanical research were established in the 1920s. They were the Department of Botany, Biological Laboratory of the Science Society of China (1922, Nanjing), the Fan Memorial Institute of Biology (1928, Beiping), and the Institute of Botany, Beiping Academy of Sciences (1929, Beiping). 相似文献